194 related articles for article (PubMed ID: 36637953)
1. High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma.
Liu B; Su J; Fan B; Ni X; Jin T
Medicine (Baltimore); 2023 Jan; 102(2):e32667. PubMed ID: 36637953
[TBL] [Abstract][Full Text] [Related]
2. KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification.
Wang H; Ma X; Li S; Su J; Fan B; Liu B; Ni X
Aging (Albany NY); 2023 May; 15(11):4714-4733. PubMed ID: 37310408
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
Xie C; Yiu W; Mo Y
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer.
Chen H; Zhang L; Zuo M; Lou X; Liu B; Fu T
Aging (Albany NY); 2023 Feb; 15(4):1210-1227. PubMed ID: 36849137
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J
J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
[TBL] [Abstract][Full Text] [Related]
8. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
Wu F; Wu S; Gou X
Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
10. The high expression of TOP2A and MELK induces the occurrence of psoriasis.
Zhu X; Zhang E; Qin L
Aging (Albany NY); 2024 Feb; 16(4):3185-3199. PubMed ID: 38382096
[TBL] [Abstract][Full Text] [Related]
11. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
13. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
16. PLK1 as one novel target for the poor prognosis of bladder cancer: An observational study.
Liu B; Meng LB; Su JZ; Fan B; Zhao SB; Wang HY; Li T; Wang TY; Zhang AL; Ni XC
Medicine (Baltimore); 2022 Sep; 101(39):e30723. PubMed ID: 36181054
[TBL] [Abstract][Full Text] [Related]
17. CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Feb; 102(6):e32825. PubMed ID: 36820589
[TBL] [Abstract][Full Text] [Related]
18. Analysis and verification of
Yang Z; Peng B; Pan Y; Gu Y
Bioengineered; 2021 Dec; 12(2):9473-9483. PubMed ID: 34699322
[No Abstract] [Full Text] [Related]
19. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
